These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11916364)

  • 1. Apoptosis--new opportunities for novel therapeutics for heart diseases.
    Feuerstein GZ
    Cardiovasc Drugs Ther; 2001 Nov; 15(6):547-51. PubMed ID: 11916364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis in cardiac diseases--new opportunities for novel therapeutics for heart diseases.
    Feuerstein GZ
    Cardiovasc Drugs Ther; 1999 Jul; 13(4):289-94. PubMed ID: 10516863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis in cardiac diseases: stress- and mitogen-activated signaling pathways.
    Feuerstein GZ; Young PR
    Cardiovasc Res; 2000 Feb; 45(3):560-9. PubMed ID: 10728377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis in cardiac disease: from basics to clinics--an editorial commentary.
    Paul M
    Cardiovasc Drugs Ther; 2001 Nov; 15(6):553-4. PubMed ID: 11916365
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol.
    Yue TL; Ma XL; Wang X; Romanic AM; Liu GL; Louden C; Gu JL; Kumar S; Poste G; Ruffolo RR; Feuerstein GZ
    Circ Res; 1998 Feb; 82(2):166-74. PubMed ID: 9468187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated polymorphonuclear leukocytes induce cardiomyocyte apoptosis and the protective effects of carvedilol.
    Dun Y; Zhi JM; Sun HY; Zhao RR; Zhao ZQ
    Methods Find Exp Clin Pharmacol; 2002 Sep; 24(7):403-12. PubMed ID: 12428428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carvedilol inhibits activation of stress-activated protein kinase and reduces reperfusion injury in perfused rabbit heart.
    Yue TL; Ma XL; Gu JL; Ruffolo RR; Feuerstein GZ
    Eur J Pharmacol; 1998 Mar; 345(1):61-5. PubMed ID: 9593595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
    Ruffolo RR; Feuerstein GZ
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohormonal activation, oxygen free radicals, and apoptosis in the pathogenesis of congestive heart failure.
    Ruffolo RR; Feuerstein GZ
    J Cardiovasc Pharmacol; 1998; 32 Suppl 1():S22-30. PubMed ID: 9731692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection.
    Feuerstein GZ; Ruffolo RR
    Eur Heart J; 1996 Apr; 17 Suppl B():24-9. PubMed ID: 8733068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-arrestin-biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction.
    Carr R; Schilling J; Song J; Carter RL; Du Y; Yoo SM; Traynham CJ; Koch WJ; Cheung JY; Tilley DG; Benovic JL
    Proc Natl Acad Sci U S A; 2016 Jul; 113(28):E4107-16. PubMed ID: 27354517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol: preclinical profile and mechanisms of action in preventing the progression of congestive heart failure.
    Ruffolo RR; Feuerstein GZ
    Eur Heart J; 1998 Feb; 19 Suppl B():B19-24. PubMed ID: 9519348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carvedilol in ischemic heart failure. Hibernating myocardium resuscitated].
    MMW Fortschr Med; 2003 Feb; 145(8):57. PubMed ID: 12661451
    [No Abstract]   [Full Text] [Related]  

  • 14. Carvedilol for heart failure: renewed interest in beta blockers.
    Young JB
    Cleve Clin J Med; 1997 Sep; 64(8):415-22. PubMed ID: 9308217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carvedilol treatment after myocardial infarct decreases cardiomyocytic apoptosis in the peri-infarct zone during cardioplegia-induced cardiac arrest.
    Yeh CH; Chen TP; Wang YC; Lin YM; Fang SW
    Shock; 2013 Apr; 39(4):343-52. PubMed ID: 23481492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol in the treatment of chronic heart failure.
    Moe G
    Expert Opin Pharmacother; 2001 May; 2(5):831-43. PubMed ID: 11336626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using carvedilol to treat heart failure.
    Taccetta-Chapnick M
    Crit Care Nurse; 2002 Apr; 22(2):36-40, 42-6, 48 passim. PubMed ID: 11961943
    [No Abstract]   [Full Text] [Related]  

  • 18. Carvedilol: the new role of beta blockers in congestive heart failure.
    Vanderhoff BT; Ruppel HM; Amsterdam PB
    Am Fam Physician; 1998 Nov; 58(7):1627-34, 1641-2. PubMed ID: 9824960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase in apoptosis of human monoblastic leukemia U937 cells by lectin-II isolated from Korean mistletoe.
    Pae HO; Oh GS; Kim NY; Shin MK; Lee HS; Yun YG; Oh H; Kim YM; Chung HT
    In Vitr Mol Toxicol; 2001; 14(2):99-106. PubMed ID: 11690563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of carvedilol alone versus carvedilol + pimobendan for severe congestive heart failure. For the Keio Interhospital Cardiology Study (KICS) Group.
    Yoshikawa T; Baba A; Suzuki M; Yokozuka H; Okada Y; Nagami K; Takahashi T; Mitamura H; Ogawa S
    Am J Cardiol; 2000 Jun; 85(12):1495-7; A7. PubMed ID: 10856401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.